Listen

Description

Allan Horwich, Partner, ArentFox Schiff, and Crista Brawley, Associate Vice President for Research, Northwestern University, discuss insider trading in the clinical trial setting. They cover the basics of the law of insider trading, the regulatory process for the approval of a new drug by the FDA, confidentiality agreements, risks related to confidential information and disseminating information on public forums, and SEC enforcement. Allan and Crista recently authored an article for AHLA’s Journal of Health and Life Sciences Law about this issue.

Essential Legal Updates, Now in Audio

AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

Stay At the Forefront of Health Legal Education

Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.